Gait speed and neurocognitive disorders: a comprehensive systematic review and meta-analysis.
Key claim: Slow gait speed and gait-speed decline are significantly associated with higher risk of dementia and cognitive impairment (e.g., slow GS HR 1.47; ≥0.05 m/s decrement HR 2.01), supporting gait speed as an early screening marker for neurocognitive disorders.
Abstract
UNLABELLED: Gait reflects cognitive function and may serve as a window into cognitive health. This study investigates the relationship between gait speed (GS) and the onset of cognitive impairments. A systematic review and meta-analysis of cohort and longitudinal studies from PubMed, Scopus, and Web of Science (up to July 2024) was conducted. Hazard ratios (HR) were analyzed using R software. Forty studies were included. Slow GS showed an HR of 1.47 (1.19-1.82) for dementia risk. A GS decrement of ≥0.05 m/s resulted in an HR of 2.01 (1.34-3.01). A faster baseline GS was not significantly associated with a reduced risk of dementia (HR 0.97, 0.94-1.01). Subjective GS decrement displayed an HR of 1.74 (1.61-1.87). Declining GS and slower gait performance are significant factors for cognitive impairment. GS may serve as an early indicator for neurocognitive disorders. Regular GS assessments should be embedded into screening programs for older adults to help mitigate cognitive decline. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at https://doi.org/10.1007/s40200-026-02073-5.
Why this matters
Gait speed is one of the cheapest, most reproducible functional measurements available, and a pooled 40-study meta-analysis quantifying its association with dementia risk raises its standing as a screening layer that sits upstream of expensive biomarker and imaging workups. In an area dominated by molecular clocks with unclear predictive validity, a simple timed-walk with HR ~1.5 for slow gait and ~2.0 for measurable decline is a reminder that observable function still tracks outcomes competitively.